Holen Sie sich die Stockscreener-App
1.07
0.00%
0.00
Handel nachbörslich:
1.05
-0.02
-1.87%
Schlusskurs vom Vortag:
$1.07
Offen:
$1.05
24-Stunden-Volumen:
1.89M
Relative Volume:
1.02
Marktkapitalisierung:
$405.52M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.1263
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
-6.14%
1M Leistung:
+0.94%
6M Leistung:
-42.16%
1J Leistung:
-59.62%
1-Tages-Spanne:
$1.00
$1.07
1-Wochen-Bereich:
$1.00
$1.19
52-Wochen-Spanne:
$0.99
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.07 | 405.52M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
124.44 | 215.82B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
345.80 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
BSX
Boston Scientific Corp
|
89.70 | 132.67B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
82.88 | 106.28B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.36 | 40.63B | 5.72B | 4.17B | 259.90M | 6.97 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Swiss National Bank - Defense World
What Will Standard BioTools Inc (NASDAQ: LAB) Be Like In 2025 - Stocks Register
Charles Schwab Investment Management Inc. Sells 112,434 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Bank of New York Mellon Corp Reduces Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools at KeyBanc Forum: Strategic Moves in Plasma Proteomics By Investing.com - Investing.com Canada
STANDARD BIOTOOLS INC. SEC 10-K Report - TradingView
Rhumbline Advisers Sells 10,975 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock - Investing.com India
Casdin Partners master fund buys $5.13 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $5.13 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Q1 Earnings Forecast for Standard BioTools Issued By KeyCorp - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
ARK Investment Management LLC Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Participate in Upcoming Investor Conferences -February 27, 2025 at 04:02 pm EST - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges - TipRanks
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc - TipRanks
Standard BioTools Sets March Investor Conference Schedule: What Financial Updates Might Be Revealed? - StockTitan
Standard BioTools Shares Fall After Downgrade From KeyBanc -February 27, 2025 at 01:59 pm EST - Marketscreener.com
Standard BioTools stock downgraded at KeyBanc (LAB:NASDAQ) - Seeking Alpha
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript - Insider Monkey
KeyBanc Downgrades Standard BioTools to Sector Weight From Overweight, Removes $4 Price Target - Marketscreener.com
KeyBanc cuts Standard BioTools stock rating on revenue concerns - Investing.com India
KeyBanc cuts Standard BioTools stock rating on revenue concerns By Investing.com - Investing.com South Africa
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Standard BioTools: Q4 Earnings Snapshot - CTPost
Standard BioTools reports Q4 EPS (9c), consensus (3c) - TipRanks
Standard BioTools Reports 2024 Financial Results - TipRanks
Buy Rating for Standard BioTools: Balancing Challenges with Strategic Growth Initiatives - TipRanks
Standard BioTools: Q4 Earnings Snapshot -February 26, 2025 at 06:53 pm EST - Marketscreener.com
Earnings call transcript: Standard BioTools Q4 2024 misses forecasts, stock dips - Investing.com
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools Reports 2024 Financial Results and Strategic Outlook - TipRanks
Can Standard BioTools' Massive $90M Cost Cuts Offset Declining Revenue? - StockTitan
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Fluidigm stock hits 52-week low at $1.17 amid market challenges By Investing.com - Investing.com South Africa
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results -February 26, 2025 at 04:02 pm EST - Marketscreener.com
Fluidigm stock hits 52-week low at $1.17 amid market challenges - Investing.com
Shareholders in Standard BioTools (NASDAQ:LAB) have lost 66%, as stock drops 10.0% this past week - Yahoo Finance
Standard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Analysts review Standard BioTools Inc’s rating - Knox Daily
Standard BioTools (LAB) to Release Quarterly Earnings on Wednesday - MarketBeat
Market Cool On Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 28% Lower - Simply Wall St
Standard BioTools (NASDAQ:LAB) Stock Price Up 7.1%Here's What Happened - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 2,960,169 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):